Literature DB >> 8729151

Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes.

S L Wang1, J Head, L Stevens, J H Fuller.   

Abstract

OBJECTIVE: To determine the extent that mortality in IDDM and NIDDM patients is in excess of that of the general population and examine its relation to hypertension and proteinuria in diabetic patients. RESEARCH DESIGN AND METHODS: A stratified random sample of 4,714 diabetic patients aged 35-55 years participating in the World Health Organization Multinational Study of Vascular Disease in Diabetes has been followed up from 1975 to 1987. Excess mortality, compared with the background population, was assessed in terms of standardized mortality ratios (SMRs) for each of the 10 international cohorts. The relationship between excess mortality and proteinuria/hypertension was examined by diabetes type and sex.
RESULTS: SMRs were in general higher in patients with IDDM (ranging from 188 to 686 for men and from 336 to 790 for women) than with NIDDM (from 138 to 370 for men and from 126 to 435 for women). For both diabetes types and in both sexes, SMRs decreased with increasing age and increased with increasing diabetes duration. Patients with both hypertension and proteinuria experienced a strikingly high mortality risk: 11-fold for men with IDDM and 18-fold for women with IDDM and 5-fold for men with NIDDM and 8-fold for women with NIDDM. Even in the absence of proteinuria and hypertension, SMRs were significantly increased in both IDDM (284 men and 360 women) and NIDDM (192 men and 236 women) patients.
CONCLUSIONS: Considerable international differences were found not only in mortality rates for the two types of diabetes but also in the extent of excess mortality among centers. IDDM patients had a high excess mortality in comparison with the general population. The significant excess mortality was demonstrated even in patients without proteinuria and without hypertension for both sexes and diabetes types.

Entities:  

Mesh:

Year:  1996        PMID: 8729151     DOI: 10.2337/diacare.19.4.305

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

2.  An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

Authors:  A Y T Wu; N C T Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; M R Weir
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

3.  Differences in the diagnosis and management of type 2 diabetes in 3 countries (US, UK, and Germany): results from a factorial experiment.

Authors:  Olaf von dem Knesebeck; Eric Gerstenberger; Carol Link; Lisa Marceau; Martin Roland; Stephen Campbell; Johannes Siegrist; Werner de Cruppé; John McKinlay
Journal:  Med Care       Date:  2010-04       Impact factor: 2.983

4.  Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.

Authors:  R D Feldman; N R Campbell; P Larochelle
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

5.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

6.  Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.

Authors:  R Valdez; K M Narayan; L S Geiss; M M Engelgau
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

Review 7.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

8.  Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.

Authors:  Thomas E Delea; Oleg Sofrygin; James L Palmer; Helen Lau; Veronica C Munk; Jennifer Sung; Alan Charney; Hans-Henrik Parving; Sean D Sullivan
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

9.  Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.

Authors:  Allon N Friedman; Mary Chambers; Lisa M Kamendulis; Joan Temmerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 8.237

10.  16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study.

Authors:  Lars J Hansen; Niels de Fine Olivarius; Volkert Siersma
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.